are all tirzepatide compounds the same Impurity in Some Compounded 'Potentially Dangerous,' Eli Lilly Warns Compounded Tirzepatide Program: Results, Timeline

What Conditions May Qualify Someone For An Ozempic Lawsuit

Targeted therapy modulating cell signaling pathways can be a powerful strategy to design new drugs to treat asthma

Future updates to guidelines may include more details on when to use semaglutide for patients with mixed metabolic issues , such as obesity and high cholesterol without diabetes

Despite headline-grabbing clinical results (up to 22% weight loss in trials), studies show average weight reduction in routine care is typically 28% after a year, with only about one third of patients achieving greater than 5% loss

The Salt Form Controversy: Chemical Identity and Regulatory Evasion A critical battleground in the current GLP-1 litigation involves the chemical form of the active ingredient